p12DOC-1, a growth suppressor, associates with DNA polymerase alpha/primase

Authors:

Abstract
P12DOC-1 is a growth suppressor identified and isolated from normal keratinocytes. Ectopic expression of p12DOC-1 in squamous carcinoma cells led to the reversion of in vitro transformation phenotypes including anchorage independence, doubling time, and morphology. Here we report that p12DOC-1 associates with DNA polymerase α/primase (pol-α:primase) in vitro and in cells. The pol-α:primase binding domain in p12DOC-1 is mapped to the amino-terminal six amino acid (MSYKPN). The biological effect of p12DOC-1 on pol-α:primase was examined using in vitro DNA replication assays. Using the SV40 DNA replication assay, p12DOC-1 suppresses DNA replication, leveling at ∼50%. Similar results were obtained using the M13 single-stranded DNA synthesis assay. Analysis of the DNA replication products revealed that p12DOC-1 affects the initiation step, not the elongation phase. The p12DOC-1 suppression of DNA replication is likely to be mediated either by a direct inhibitory effect on pol-α:primase or by its effect on cyclin-dependent kinase 2 (CDK2), a recently identified p12DOC-1-associated protein known to stimulate DNA replication by phosphorylating pol-α:primase. p12DOC-1 suppresses CDK2-mediated phosphorylation of pol-α:primase. These data support a role of p12DOC-1 as a regulator of DNA replication by direct inhibition of pol-α:primase or by negatively regulating the CDK2-mediated phosphorylation of pol-α:primase.—Matsuo, K., Shintani, S., Tsuji, T., Nagata, E., Lerman, M., McBride, J., Nakahara, Y., Ohyama, H., Todd, R., Wong, D. T. W. p12DOC-1, a growth suppressor, associates with DNA polymerase α/primase.